759
Views
13
CrossRef citations to date
0
Altmetric
Review

Upper extremity function and activity in facioscapulohumeral dystrophy and limb-girdle muscular dystrophies: a systematic review

, , &
Pages 1017-1032 | Received 29 Oct 2013, Accepted 21 Jul 2014, Published online: 07 Aug 2014

References

  • Emery AEH. The muscular dystrophies. Lancet 2002;359:687–95
  • Janssen MM, Bergsma A, Geurts AC, et al. Patterns of decline in upper limb function of boys and men with DMD: an international survey. J Neurol 2014;261:1269--88
  • Padberg GW, Frants RR, Brouwer OF, et al. Facioscapulohumeral muscular dystrophy in the Dutch population. Muscle Nerve 1995;18:S81–4
  • Emery AEH. Population frequencies of inherited neuromuscular diseases – a world survey. Neuromus Disord 1991;1:19–29
  • Pandya S, King WM, Tawil R. Facioscapulohumeral dystrophy. Phys Ther 2008;88:105–13
  • Tawil R, Van der Maarel SM. Facioscapulohumeral muscular dystrophy. Muscle Nerve 2006;34:1–15
  • Guglieri M, Bushby K. How to go about diagnosing and managing the limb-girdle muscular dystrophies. Neurol India 2008;56:271–80
  • Cup EH, Pieterse AJ, ten Broek-Pastoor JM, et al. Exercise therapy and other types of physical therapy for patients with neuromuscular diseases: a systematic review. Arch Phys Med Rehabil 2007;88:1452–64
  • Cup EHC, Sturkenboom IHWM, Pieterse AJ, et al. The evidence for occupational therapy for adults with neuromuscular diseases: a systematic review. OTJR Occup Particip Health 2008;28:12–18
  • Knuijt S, Cup EHC, Pieterse AJ, et al. Speech pathology interventions in patients with neuromuscular diseases: a systematic review. Folia Phoniatr Logop 2011;63:15–20
  • World Health Organization. International Classification of Functioning, Disability and Health (ICF). Geneva: World Health Organization; 2001
  • Brouwer OF, Padberg GW, Van der Ploeg RJO, et al. The influence of handedness on the distribution of muscular weakness of the arms in facioscapulohumeral muscular dystrophy. Brain 1992;115:1587–98
  • FSH-DY-Group. A prospective, quantitative study of the natural history of facioscapulohumeral muscular dystrophy (FSHD): implications for therapeutic trials. The FSH-DY Group. Neurology 1997;48:38–46
  • Rozman J, Bunc M, Zupan A. Evaluation of the strength of elbow flexors in patients with neuromuscular diseases. J Med Eng Technol 2001;25:235–9
  • Kilmer DD, Abresch RT, McCrory MA, et al. Facioscapulohumeral muscular dystrophy. Am J Phys Med Rehabil 1995;74:S131–9
  • Munsat TL. Facioscapulohumeral dystrophy and the scapuloperoneal syndrome. In: Engel AG, Banker BQ, eds. Myology: basic and clinical. New York: McGraw-Hill; 1986:1251–66
  • Lord JP, Portwood MM, Fowler WM, et al. Upper vs lower extremity functional loss in neuromuscular disease. Arch Phys Med Rehabil 1987;68:8–9
  • Lue YJ, Chen SS. The strength and functional performance in patients with facioscapulohumeral muscular dystrophy. Kaohsiung J Med Sci 2000;16:248–54
  • Lue Y-J, Lin RF, Chen SS, et al. Measurement of the functional status of patients with different types of muscular dystrophy. Kaohsiung J Med Sci 2009;25:325–33
  • Personius KE, Pandya S, King WM, et al. Facioscapulohumeral Dystrophy Natural History Study: standardization of testing procedures and reliability of measurements. Phys Ther 1994;74:253–63
  • Tawil R, Mcdermott MP, Mendell JR, et al. Facioscapulohumeral Muscular Dystrophy (FSHD) – design of natural history study and results of baseline testing. Neurology 1994;44:442–6
  • Stubgen J-P, Stipp A. Facioscapulohumeral muscular dystrophy: a prospective study of weakness and functional impairment. J Neurol 2010;257:1457–64
  • Lue YJ, Chen SS. Strength and functional performance of patients with limb-girdle muscular dystrophy. Kaohsiung J Med Sci 2000;16:83–90
  • Mahjneh I, Marconi G, Bushby K, et al. Dysferlinopathy (LGMD2B): a 23-year follow-up study of 10 patients homozygous for the same frameshifting dysferlin mutations. Neuromus Disord 2001;11:20–6
  • McDonald CM, Johnson ER, Abresch RT, et al. Profiles of neuromuscular diseases. Limb-girdle syndromes. Am J Phys Med Rehabil 1995;74:S117–30
  • Walton JN. Clinical examination of the neuromuscular system. In: Walton JN, ed. Disorders of voluntary muscle. Edinburgh; New York: Churchill Livingstone; 1981:448--80
  • Stubgen JP, Lahouter A. Limb girdle muscular dystrophy: weakness and disease duration as predictors of functional impairment. Muscle Nerve 1994;17:873–80
  • Stubgen JP, Stipp A. Limb girdle muscular dystrophy: a prospective follow-up study of functional impairment. Muscle Nerve 1997;20:453–60
  • Stubgen JP. Limb girdle muscular dystrophy: an interval study of weakness and functional impairment. J Clin Neuromus Dis 2008;9:333–40
  • Wadsworth CT, Krishnan R, Sear M, et al. Intrarater reliability of manual muscle testing and hand-held dynametric muscle testing. Phys Ther 1987;67:1342–7
  • Brooke MH, Griggs RC, Mendell JR, et al. Clinical trial in Duchenne dystrophy. I. The design of the protocol. Muscle Nerve 1981;4:186–97
  • Mahoney FI, Barthel DW. Functional evaluation: the Barthel index. Maryland State Med J 1965;14:61–5
  • World Health Organization. Towards a common language for functioning, disability and health: ICF. Geneva: WHO; 2002
  • Bakhtiary AH, Phoenix J, Edwards RHT, et al. The effect of motor learning in facioscapulohumeral muscular dystrophy patients. Eur J Appl Physiol 2000;83:551–8
  • Jebsen RH, Taylor N, Trieschmann RB, et al. An objective and standardized test of hand function. Arch Phys Med Rehabil 1969;50:311–19
  • Penta M, Thonnard JL, Tesio L. ABILHAND: a Rasch-built measure of manual ability. Arch Phys Med Rehabil 1998;79:1038–42
  • Vandervelde L, Van Den Bergh PYK, Penta M, et al. Validation of the ABILHAND questionnaire to measure manual ability in children and adults with neuromuscular disorders. J Neurol Neurosurg Psychiat 2010;81:506–12
  • Hudak PL, Amadio PC, Bombardier C. Development of an upper extremity outcome measure: the DASH (disabilities of the arm, shoulder, and head). Am J Indust Med 1996;29:602–8

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.